Develops products for eye care and wound management, focusing on antimicrobial solutions and ophthalmic devices.
NovaBay Pharmaceuticals, Inc., headquartered in Emeryville, California, is a dynamic pharmaceutical company specializing in the development and global distribution of innovative eyecare and skincare products. Founded in 2000 as NovaCal Pharmaceuticals, the company rebranded to NovaBay Pharmaceuticals, Inc. in 2007 to reflect its expanded focus and commitment to advancing healthcare solutions.
The company's flagship product, Avenova, stands out as a groundbreaking solution designed to effectively remove microorganisms and debris from the skin around the eye, particularly the eyelid. NovaBay also offers a range of wound care products under the NeutroPhase and PhaseOne brands, catering to diverse medical needs.
In addition to its eyecare offerings, NovaBay Pharmaceuticals provides comprehensive dermatological solutions addressing various skincare concerns. These include treatments for conditions like keratosis pilaris, rosacea, eczema, anti-aging solutions, SPF protection, hyperhidrosis, excessive hair, and acne, marketed under the DERMAdoctor brand. Leveraging retail partnerships, digital beauty channels, distributors, and online platforms, NovaBay Pharmaceuticals continues to expand its global reach, delivering innovative products that enhance patient care and wellbeing worldwide.